Acceptance and Commitment Therapy for Caregivers of Children with Genetic Syndromes
Trial Summary
What is the purpose of this trial?
Background: RASopathies are a group of genetic diseases that affect a child s development. They cause physical, cognitive, and behavioral symptoms. Caring for a child with a RASopathy can be stressful. Acceptance and Commitment Therapy (ACT) is a therapy that helps people become more aware and accepting of difficult thoughts and feelings. ACT has been found to be helpful for parents with high parenting stress. Objective: To find out if Acceptance and Commitment Therapy (ACT) can help caregivers of children with a RASopathy better cope with parenting stress. Eligibility: People aged 18 years or older who care for a child (younger than 18 years) with a RASopathy. The child must live with the caregiver at least 50% of the time. Design: The study is fully remote. Participants need a mobile device that can play audio and video and connect to the internet. They can borrow an iPod if needed. Participants will download a free app called MetricWire. They will use this app to watch videos and answer questions. The first 8 participants will be in a pilot study. They will receive the ACT intervention starting the first week after they begin the study. After the pilot study, we will start a new phase called the randomized trial. In this phase, participants will have a 50-50 chance of being in the group that will start the intervention right away or the group that will start the intervention after about 2 months. Participants will fill out surveys on 5 random days each week. These surveys have 7 questions and take about 2 minutes. They will also fill out 3 longer questionnaires: once before ACT begins, once just after the 8-week study period, and once about 3 months later. Questions will cover topics including: Parenting stress Life satisfaction Self-compassion Uncomfortable feelings and thoughts Mindfulness Participants will take part in an 8-week ACT intervention. They will have one 75-minute session with an ACT coach in the first week. Participants will watch 9- to 17-minute videos each week. The videos talk about how to practice ACT techniques to cope with parenting stress. Participants will have 20- to 30-minute coaching sessions in weeks 3 and 6. The coach will help them practice exercises and work through any problems.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop your current medications. However, if you started taking psychiatric medication less than 4 weeks before enrolling, you may not be eligible.
What data supports the effectiveness of the treatment Acceptance and Commitment Therapy (ACT) for caregivers of children with genetic syndromes?
Research shows that Acceptance and Commitment Therapy (ACT) can help reduce stress, anxiety, and depression, and improve quality of life in various groups, including parents of children with chronic conditions. This suggests it may also be beneficial for caregivers of children with genetic syndromes.12345
Is Acceptance and Commitment Therapy (ACT) safe for humans?
How is Acceptance and Commitment Therapy (ACT) different from other treatments for caregivers of children with genetic syndromes?
Research Team
Staci M Peron, Ph.D.
Principal Investigator
National Cancer Institute (NCI)
Eligibility Criteria
This trial is for caregivers aged 18 or older who look after a child with a RASopathy syndrome, such as Neurofibromatosis or Noonan Syndrome. The child must live with them at least half the time. Caregivers should be experiencing moderate parenting stress and have access to technology like smartphones or computers for remote participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Internal Pilot Study
Initial cohort of 8 participants undergoes the ACT intervention to assess feasibility and acceptability
Randomized Controlled Trial (RCT)
Participants are randomized to either immediate intervention or waitlist control, with intervention starting after a 1-week baseline period
Follow-up
Participants are monitored for changes in parenting stress and other psychological measures post-intervention
Treatment Details
Interventions
- Acceptance and Commitment Therapy (ACT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Cancer Institute (NCI)
Lead Sponsor